Latest News From Lumira Ventures

KAI Pharmaceuticals, Inc. Acquires Patents from Progen Pharmaceuticals Limited, Broadening KAI’s Intellectual Property Estate Covering Peptide-Based Therapies

admin KAI Pharmaceuticals, Portfolio News

Published: Jun 30, 2009 SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, announced today the acquisition of an extensive collection of issued and pending patents from Progen Pharmaceuticals Limited (ASX: PGL; Nasdaq:PGLA), a …